Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWZalcitabine is a nucleoside reverse transcriptase inhibitor (NRTI).1 It is phosphorylated intracellularly to its active form zalcitabine-5’-triphosphate by the successive actions of deoxycytidine kinase, deoxycytidine monophosphate kinase, and nucleoside diphosphate kinase.2 Zalcitabine reduces the replication of laboratory-adapted and clinical isolates of HIV in a plaque reduction assay (IC50s = 0.013-0.08 µM).3 Formulations containing zalcitabine have been used in the treatment of HIV infection.
WARNING This product is not for human or veterinary use.
1. Zalcitabine. Clinical pharmacokinetics and efficacy. Clin. Pharmacokinet. 28(5), 351-360 (1995).
2. The cellular pharmacology of nucleoside-
3. Susceptibilities of zidovudine-